Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Read More…
Industry, Sector and Symbol
Industry Sanitary services
Sub-IndustryEnvironmental & Facilities Services
SectorBusiness Services
Phone847-367-5910
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.49 billion
Profitability
Miscellaneous
Employees22,500
Next Earnings Date8/1/2019 (Estimated)
OptionableOptionable
Stericycle (NASDAQ:SRCL) Frequently Asked Questions
What is Stericycle's stock symbol?
Stericycle trades on the NASDAQ under the ticker symbol "SRCL."
How were Stericycle's earnings last quarter?
Stericycle Inc (NASDAQ:SRCL) released its quarterly earnings results on Thursday, May, 2nd. The business services provider reported $0.57 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.87 by $0.30. The business services provider had revenue of $830.10 million for the quarter, compared to the consensus estimate of $866.19 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%. The business's revenue for the quarter was down 7.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.21 earnings per share. View Stericycle's Earnings History.
When is Stericycle's next earnings date?
What price target have analysts set for SRCL?
7 equities research analysts have issued 1 year price objectives for Stericycle's stock. Their predictions range from $44.00 to $75.00. On average, they expect Stericycle's stock price to reach $56.6667 in the next year. This suggests a possible upside of 25.3% from the stock's current price. View Analyst Price Targets for Stericycle.
What is the consensus analysts' recommendation for Stericycle?
7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stericycle in the last year. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Stericycle.
What are Wall Street analysts saying about Stericycle stock?
Here are some recent quotes from research analysts about Stericycle stock:
- 1. According to Zacks Investment Research, "Stericycle’s first-quarter 2019 earnings and revenues lagged the Zacks Consensus Estimate. Decline in Communication and Related Services businesses is weighing on Stericycle’s top line. A highly-competitive waste management industry will put Stericycle under pricing pressure. Global presence exposes Stericycle to foreign currency exchange rate risks. High debt may limit the company’s future expansion and worsen its risk profile. The stock has under performed its industry in the past six months. Despite such headwinds, Stericycle is making progress with Business Transformation initiatives, aimed at improving long-term operational and financial performance. The company continues to increase its market share and expand geographic base with the help of acquisitions. Stericycle's focus on providing regulated business-to-business services to smaller businesses should expand its offerings and boost the company's profits." (5/7/2019)
- 2. Robert W. Baird analysts commented, "Driven by the successful turnaround efforts at Terminix and solid performance in FSG, adjusted EBITDA of $105M was in line with our estimate and beat the Street’s $101M estimate; revenues of $496M also beat our/Street’s $489M/$486M estimates. Management raised FY2018 revenue guidance to $1,885-1,900M ($1,875M-$1,890M previously), owing to the transformation efforts and performance of acquisitions at Terminix. The company reiterated adjusted EBITDA guidance of $425-435M, as it continues to invest in the business to create sustainable, long-term growth. Maintain Outperform." (11/6/2018)
Has Stericycle been receiving favorable news coverage?
Press coverage about SRCL stock has trended somewhat positive on Sunday, InfoTrie Sentiment reports. The research group identifies negative and positive press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Stericycle earned a daily sentiment score of 1.7 on InfoTrie's scale. They also assigned news articles about the business services provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for Stericycle.
Who are some of Stericycle's key competitors?
What other stocks do shareholders of Stericycle own?
Who are Stericycle's key executives?
Stericycle's management team includes the folowing people:
- Ms. Cindy J. Miller, Pres, CEO & Director (Age 56)
- Mr. Daniel V. Ginnetti, Exec. VP & CFO (Age 50)
- Mr. Kurt M. Rogers, Exec. VP, Gen. Counsel & Corp. Sec. (Age 47)
- Ms. Ruth-Ellen Abdulmassih, Advisor (Age 57)
- Mr. Richard Joseph Hoffman, Sr. VP & Chief Accounting Officer (Age 52)
Who are Stericycle's major shareholders?
Stericycle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.21%), Baillie Gifford & Co. (5.92%), Clarkston Capital Partners LLC (4.52%), Iridian Asset Management LLC CT (3.41%), Wells Fargo & Company MN (2.91%) and FMR LLC (2.89%). Company insiders that own Stericycle stock include Brian P Anderson, Charles A Alutto, Daniel Ginnetti, Jack W Schuler, John Patience, Mark C Miller and Thomas D Brown. View Institutional Ownership Trends for Stericycle.
Which major investors are selling Stericycle stock?
SRCL stock was sold by a variety of institutional investors in the last quarter, including Thompson Siegel & Walmsley LLC, Wells Fargo & Company MN, BlackRock Inc., Duality Advisers LP, Tyers Asset Management LLC, Sasco Capital Inc. CT, Royal London Asset Management Ltd. and Fiduciary Trust Co.. Company insiders that have sold Stericycle company stock in the last year include Brian P Anderson, Daniel Ginnetti and Mark C Miller. View Insider Buying and Selling for Stericycle.
Which major investors are buying Stericycle stock?
SRCL stock was acquired by a variety of institutional investors in the last quarter, including Iridian Asset Management LLC CT, FMR LLC, New York State Common Retirement Fund, SG Americas Securities LLC, Knott David M, Neuberger Berman Group LLC, Callodine Capital Management LP and Sapience Investments LLC. Company insiders that have bought Stericycle stock in the last two years include Brian P Anderson and Jack W Schuler. View Insider Buying and Selling for Stericycle.
How do I buy shares of Stericycle?
Shares of SRCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Stericycle's stock price today?
One share of SRCL stock can currently be purchased for approximately $45.24.
How big of a company is Stericycle?
Stericycle has a market capitalization of $4.12 billion and generates $3.49 billion in revenue each year. The business services provider earns $-244,700,000.00 in net income (profit) each year or $4.45 on an earnings per share basis. Stericycle employs 22,500 workers across the globe.View Additional Information About Stericycle.
What is Stericycle's official website?
How can I contact Stericycle?
Stericycle's mailing address is 28161 NORTH KEITH DRIVE, LAKE FOREST IL, 60045. The business services provider can be reached via phone at 847-367-5910 or via email at [email protected]
MarketBeat Community Rating for Stericycle (NASDAQ SRCL)
MarketBeat's community ratings are surveys of what our community members think about Stericycle and other stocks. Vote "Outperform" if you believe SRCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
